Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,17070,691,1.11 [0.96-1.28],0.1643732721851997
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,16541,196,1.07 [0.81-1.42],0.6338508371288277
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,18845,114,1.26 [0.94-1.68],0.1173000250853326
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,12713,652,0.98 [0.83-1.17],0.8437263154167053
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,18810,79,1.35 [0.97-1.86],0.0713525272930992
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,17136,69,0.91 [0.54-1.53],0.7132005858606923
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",19680,78,1.32 [0.95-1.83],0.1033014200299803
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,19693,55,1.37 [0.95-1.99],0.0912437820842798
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,16788,45,1.27 [0.81-2.00],0.3030914423598139
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,18897,96,0.76 [0.46-1.25],0.2731335986268403
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other septicaemia,18864,63,0.94 [0.55-1.62],0.8272902952342384
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,19742,50,1.35 [0.92-1.97],0.1234602967906738
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other viral diseases,19769,58,1.33 [0.95-1.87],0.1018356622992868
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",19762,51,1.34 [0.93-1.92],0.1123821907840348
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Mycoses,19504,35,0.55 [0.21-1.41],0.2134872491162791
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",18737,323,0.95 [0.75-1.21],0.6867054469272539
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,18537,123,0.77 [0.49-1.19],0.2331481895945101
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,18635,221,1.00 [0.76-1.31],0.9846002670318532
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",15489,65,1.22 [0.82-1.81],0.3256962564696947
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",15460,36,1.58 [1.12-2.22],0.0095155389509366
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",15639,215,1.20 [0.96-1.49],0.1084647865320281
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",15645,221,1.20 [0.96-1.49],0.1037997975985722
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",15614,190,0.99 [0.75-1.33],0.9662951607332024
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",15466,42,0.76 [0.36-1.59],0.462583205718346
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,17619,432,1.10 [0.92-1.32],0.2980748739549143
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",18503,313,0.85 [0.65-1.10],0.2151300819541756
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,19249,105,0.93 [0.61-1.41],0.7201404923124204
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",19804,111,0.98 [0.67-1.45],0.9343735716095836
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm: Rectum,19519,63,0.98 [0.59-1.65],0.952489536229432
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,19810,52,0.95 [0.53-1.68],0.848857438479049
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm: Stomach,19851,38,0.96 [0.50-1.86],0.909402520089622
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign lipomatous neoplasm,19577,261,0.98 [0.76-1.26],0.8734452814070901
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,19817,92,1.12 [0.77-1.61],0.5565917067311421
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,19825,60,0.90 [0.52-1.56],0.7100083517634812
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",19787,29,0.90 [0.41-2.00],0.7993330537902503
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Haemangioma, any site",19790,29,0.90 [0.41-2.00],0.7989624320878559
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Melanocytic naevi,19721,100,0.84 [0.53-1.31],0.4354207838749636
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,19838,40,0.89 [0.45-1.75],0.7289038974862014
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Other benign neoplasms of skin,19743,113,1.02 [0.71-1.48],0.8963405883138243
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,18896,93,0.99 [0.65-1.50],0.9502321509094086
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,18587,188,1.06 [0.79-1.41],0.7024122183594661
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,18587,188,1.06 [0.79-1.41],0.7024122183594661
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),16755,407,1.05 [0.86-1.27],0.6276298643363698
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,19428,35,nan [nan-nan],
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,19648,48,1.33 [0.89-1.99],0.165740462365449
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,15567,1149,1.04 [0.92-1.18],0.5315235899697742
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,19288,153,1.05 [0.77-1.43],0.7460158175717458
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,17506,108,1.12 [0.79-1.59],0.5116981621590317
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Peripheral artery disease,18738,141,1.21 [0.89-1.63],0.2239393277407226
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,17496,98,1.18 [0.83-1.67],0.3617460449702648
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,17953,555,1.13 [0.95-1.34],0.1710629640301367
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,17937,539,1.13 [0.95-1.35],0.1640819126630904
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,18414,137,1.14 [0.80-1.63],0.4777660100086561
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",18415,137,1.14 [0.80-1.63],0.4817232504537732
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,15449,1031,1.03 [0.90-1.17],0.6838929648145433
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",14556,138,1.16 [0.85-1.59],0.3364007512416798
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,15372,954,0.99 [0.86-1.14],0.840403930687833
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,14454,36,1.35 [0.83-2.21],0.2241889457578305
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",14491,73,1.06 [0.67-1.66],0.8161624676823006
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,Any mental disorder,16887,582,1.08 [0.92-1.28],0.3320542039693948
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",16602,297,0.74 [0.55-1.00],0.0521311478597323
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",19392,227,0.71 [0.50-1.02],0.062642606295302
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",19461,174,0.60 [0.39-0.93],0.0226222853071838
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,18084,66,0.62 [0.31-1.21],0.1593035309151199
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",19730,66,0.65 [0.33-1.28],0.2099541590831972
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",16371,66,0.64 [0.33-1.24],0.1871609461827263
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,Alcohol dependence,18116,98,0.38 [0.20-0.72],0.0029905049697141
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,Smoking dependency,18099,74,0.79 [0.45-1.39],0.4104487784589052
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",16365,60,1.27 [0.88-1.83],0.2064963599895628
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",16522,217,1.17 [0.93-1.47],0.1737920943686042
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,Depression,18882,187,1.23 [0.97-1.55],0.0886570430891474
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,Depression or dysthymia,16303,164,1.07 [0.80-1.43],0.6380607623311921
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",16391,86,1.27 [0.92-1.75],0.1539452113996952
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,Other anxiety disorders,19011,46,1.39 [0.95-2.05],0.0923413176515799
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Neurological diseases,16939,1105,1.07 [0.96-1.21],0.2310825388258571
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,15260,77,0.86 [0.51-1.44],0.5644066236750307
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,19764,56,0.69 [0.34-1.37],0.2871972883736193
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,18749,438,1.04 [0.86-1.25],0.6936299644514672
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Epilepsy,18446,135,0.50 [0.31-0.82],0.0063301824016823
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Migraine,18340,29,0.67 [0.26-1.74],0.4137751336749558
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",19720,22,0.94 [0.38-2.29],0.8843240564923531
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Transient ischemic attack,19068,79,nan [nan-nan],
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other sleep disorders,18501,190,1.01 [0.76-1.34],0.9611432393820492
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Sleep apnoea,19248,150,1.02 [0.75-1.40],0.8820256938674399
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",19059,401,1.02 [0.84-1.25],0.8113696626480006
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",18763,105,0.84 [0.54-1.30],0.4347987028357515
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,18847,189,1.11 [0.86-1.44],0.4121546635592386
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,19591,76,0.83 [0.48-1.42],0.4921377442523073
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Hemiplegia,19564,49,0.83 [0.42-1.64],0.5895575152414565
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other neurological diseases,19438,99,1.46 [1.14-1.87],0.0030334625439414
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",19363,265,0.95 [0.74-1.22],0.6883972776099536
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,19250,152,1.07 [0.79-1.44],0.6768804879156805
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,19167,69,0.85 [0.50-1.44],0.5461838590639227
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,19185,87,0.99 [0.65-1.51],0.9608358943906654
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,19135,37,0.75 [0.34-1.68],0.4897432148132007
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,17394,117,1.12 [0.80-1.58],0.5133484854391761
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,17597,320,0.93 [0.73-1.19],0.5815570837318522
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,19041,193,0.71 [0.50-1.02],0.0677788807146066
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,19508,40,1.00 [0.53-1.86],0.9921273792116564
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,2165,40,0.95 [0.50-1.81],0.8726094491592613
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",17383,40,1.04 [0.53-2.04],0.9057429105750684
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,19295,79,0.73 [0.42-1.29],0.2837837677236591
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,19258,42,0.83 [0.40-1.71],0.6116525840477042
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",19401,63,0.74 [0.40-1.37],0.3339466013856998
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,19435,81,0.81 [0.48-1.35],0.4161857365630153
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,19771,115,0.79 [0.51-1.24],0.3045187633028637
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,19102,86,1.01 [0.66-1.55],0.9678452311428188
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,13379,3052,1.03 [0.94-1.13],0.5576557306827892
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,19286,50,0.62 [0.29-1.33],0.2202844481029703
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Hypertension, essential",14145,1988,1.03 [0.93-1.14],0.6173364100807485
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Hypertension,14169,2012,1.02 [0.92-1.13],0.6881213165870622
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,12214,57,0.92 [0.51-1.66],0.7824890264267873
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",17607,1355,1.04 [0.93-1.17],0.4586449879785582
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Angina pectoris,17004,752,1.11 [0.97-1.28],0.1397190281165495
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,18658,265,1.11 [0.89-1.39],0.3612231551459665
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,18981,588,1.04 [0.88-1.22],0.6411654002190439
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",19679,138,0.84 [0.57-1.24],0.3838755919752655
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",16662,410,0.95 [0.77-1.17],0.6565119357659066
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,17384,1151,1.04 [0.92-1.18],0.5489551179934383
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Pulmonary embolism,19125,103,1.03 [0.71-1.51],0.8702974718626159
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Venous thromboembolism,19233,211,1.33 [1.09-1.63],0.0057930573247372
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Secondary right heart disease,19099,77,1.22 [0.84-1.77],0.2887988369887686
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,19101,79,1.21 [0.83-1.75],0.3159430780488885
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",12230,73,1.26 [0.86-1.85],0.2429146004609694
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Cardiomyopathy,15638,70,1.40 [0.97-2.02],0.0702693029526227
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Conduction disorders,15708,140,1.18 [0.86-1.60],0.307376150098921
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,9871,108,1.26 [0.90-1.74],0.1759614044904039
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,10261,498,1.08 [0.90-1.30],0.4014643827169717
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other arrhythmias,15639,71,1.07 [0.67-1.70],0.7768214576497667
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,15680,112,1.24 [0.89-1.71],0.197728324625769
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Heart failure, strict",18785,265,0.94 [0.72-1.23],0.6666550620630354
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",19011,144,0.94 [0.66-1.34],0.7278279552404969
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",19034,131,0.91 [0.62-1.34],0.637410415412183
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",19104,115,0.80 [0.51-1.25],0.3323148350027782
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,18706,69,0.91 [0.53-1.57],0.7467134016936351
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,18763,126,1.25 [0.93-1.70],0.1446410475564251
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),18760,134,1.46 [1.16-1.83],0.0010725245943739
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,DVT of lower extremities,18744,118,1.46 [1.15-1.86],0.0016294216232299
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",19665,111,1.49 [1.17-1.89],0.0010470111190906
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Varicose veins,18907,281,1.18 [0.97-1.45],0.1012800846162672
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Hypotension,18838,64,1.00 [0.61-1.64],0.989143148124446
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,15516,1693,0.98 [0.88-1.09],0.7116851206882366
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,19712,72,0.88 [0.52-1.48],0.6315959307567703
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Influenza and pneumonia,18147,211,0.96 [0.72-1.28],0.767621877024212
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",18113,177,0.89 [0.64-1.25],0.5050973904146776
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,19070,234,0.89 [0.66-1.19],0.4206704894949624
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,19068,232,0.89 [0.66-1.19],0.4186489777215157
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,19130,550,0.94 [0.78-1.12],0.4779485324946646
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Chronic sinusitis,18641,61,1.13 [0.72-1.77],0.5906145622051944
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Nasal polyp,18720,140,0.77 [0.52-1.15],0.2071252393719156
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",18928,348,0.99 [0.80-1.23],0.9100580024686844
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Deviated nasal septum,18767,187,0.79 [0.56-1.12],0.1887103869077014
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,8673,49,1.24 [0.77-2.01],0.3696497027055618
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,17737,722,0.98 [0.84-1.15],0.8120796365688694
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Early onset COPD,18763,163,0.80 [0.54-1.18],0.2606165491297542
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",18786,186,0.75 [0.51-1.09],0.1350462850965732
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",18786,186,0.75 [0.51-1.09],0.1350462850965732
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",18669,558,1.03 [0.87-1.22],0.7255701561361555
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Asthma,13508,558,1.02 [0.87-1.21],0.7778860999652788
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",13222,558,1.02 [0.86-1.21],0.8027173875859617
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",13498,548,1.03 [0.87-1.22],0.7108714634433752
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,19479,96,1.35 [1.00-1.81],0.049992669878283
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Interstitial lung disease,18853,76,1.27 [0.89-1.80],0.1902271553052872
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",19551,76,1.27 [0.89-1.81],0.1819839082962282
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,18847,70,1.29 [0.90-1.85],0.1590739953700227
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Pleural effusion,17924,112,1.00 [0.68-1.45],0.9829270753866044
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other diseases of pleura,18048,236,1.07 [0.84-1.38],0.5660456158823561
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,18712,107,1.21 [0.88-1.68],0.2462728885252156
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,13245,4680,0.96 [0.89-1.04],0.31943630935579
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",19451,308,0.95 [0.75-1.20],0.6865752363144533
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,19831,62,0.77 [0.42-1.40],0.3850931693974118
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Impacted teeth,19832,59,0.82 [0.45-1.48],0.5028168278622548
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Dental caries,19238,95,1.14 [0.80-1.62],0.4769818445330703
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,19209,66,0.93 [0.56-1.56],0.7934499714358826
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,19823,71,0.93 [0.57-1.52],0.7763097544299783
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,19204,61,0.73 [0.39-1.37],0.3232103730867462
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,19022,68,1.23 [0.84-1.80],0.2810198422430938
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,19776,50,1.35 [0.92-1.98],0.119902951372695
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,15250,264,0.90 [0.69-1.19],0.4608809243136222
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",16661,1675,0.96 [0.86-1.07],0.4462234723367569
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Oesophagitis,15310,324,0.93 [0.73-1.17],0.5225203801406868
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,15542,556,0.99 [0.84-1.18],0.9434051415972552
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,15048,62,0.84 [0.47-1.50],0.5608913178550454
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,15222,236,0.88 [0.66-1.17],0.3732764051910627
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Oesophageal obstruction,15050,64,0.79 [0.43-1.43],0.4268448897598931
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Gastric ulcer,15108,122,0.94 [0.64-1.39],0.7691340823221415
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Duodenal ulcer,15136,150,1.05 [0.76-1.44],0.7853296116268005
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",19701,101,1.14 [0.80-1.62],0.4645723174530602
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Chronic gastritis,15086,100,0.86 [0.54-1.35],0.5105207489447559
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),15625,639,0.94 [0.79-1.12],0.484882759228002
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of appendix,19718,86,0.60 [0.34-1.07],0.0848199928193742
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Functional dyspepsia,15230,244,0.89 [0.68-1.18],0.4273140125219423
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,15123,137,0.84 [0.57-1.23],0.3675514084881782
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,19681,149,1.00 [0.72-1.38],0.9916175407675378
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Acute appendicitis,19700,68,0.80 [0.46-1.41],0.4488099982455313
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Hernia,16960,1701,0.95 [0.86-1.06],0.3846038733411863
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Inguinal hernia,16211,952,0.94 [0.82-1.08],0.3776065040571339
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Umbilical hernia,15399,140,0.84 [0.57-1.24],0.3774704076972681
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Ventral hernia,15336,77,0.93 [0.57-1.52],0.7864783429487586
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,15893,634,0.99 [0.84-1.16],0.885863672863151
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,19131,511,0.98 [0.82-1.17],0.8040769506725467
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of intestines,15356,1520,1.02 [0.92-1.14],0.7095008775767844
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",19562,48,0.39 [0.16-0.92],0.0325304942708562
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",19789,61,0.44 [0.20-0.93],0.0309967379485016
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Crohn disease,18681,61,0.44 [0.21-0.93],0.0314105832739401
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Crohn's disease NAS,18668,48,0.52 [0.23-1.17],0.1131704610005283
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",19740,122,0.98 [0.68-1.40],0.8962116019798377
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Ulcerative colitis,18742,122,0.97 [0.68-1.40],0.8898763268161105
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",18730,110,0.92 [0.62-1.38],0.692673917741823
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,19006,386,1.07 [0.88-1.29],0.5175114384046775
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,19004,384,1.06 [0.87-1.29],0.5475675810013847
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,13918,82,0.93 [0.59-1.49],0.7687410660901401
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Intestinal stricture,19475,82,0.93 [0.58-1.49],0.7579092443877536
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",13894,58,0.61 [0.30-1.24],0.1698244314498174
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,14269,433,1.02 [0.84-1.24],0.8360123877986565
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,13914,78,1.02 [0.65-1.58],0.94259353379336
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,13982,146,1.02 [0.74-1.41],0.8929760915409911
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Constipation,18596,133,1.03 [0.74-1.44],0.8604791184189186
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of peritoneum,19531,41,0.70 [0.31-1.55],0.379114926309529
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,13976,140,0.95 [0.67-1.36],0.7951213562822799
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,13923,87,1.01 [0.66-1.55],0.9555460084074024
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,14568,732,1.05 [0.90-1.21],0.5405466488369347
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of intestine,14104,268,0.99 [0.77-1.27],0.956628079696052
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,19521,31,0.81 [0.35-1.88],0.6217354340332111
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of liver,19130,118,0.94 [0.63-1.41],0.7710783903717047
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of liver,19079,67,1.04 [0.65-1.67],0.8741139654783767
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",18864,301,0.92 [0.72-1.18],0.5304375827667567
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Cholelithiasis,18781,218,0.93 [0.70-1.24],0.6291189328459006
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Cholecystitis,18616,53,0.94 [0.53-1.68],0.8433617495251383
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,18586,23,nan [nan-nan],
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Acute pancreatitis,18624,61,0.95 [0.56-1.64],0.8671151033119303
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),19681,61,0.96 [0.56-1.64],0.8678557632436668
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of the digestive system,18682,265,1.03 [0.81-1.32],0.7868839586134238
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Intestinal malabsorption,18444,27,1.25 [0.69-2.27],0.4638647032918849
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Coeliac disease,18437,20,1.53 [0.91-2.57],0.1111448565658995
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",18465,48,0.97 [0.54-1.77],0.9292221362256856
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,18612,195,0.99 [0.73-1.33],0.9363828147430447
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,GI-bleeding,18608,191,1.00 [0.74-1.35],0.9977764813393456
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,17269,1253,1.03 [0.92-1.16],0.5642872231608314
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,19484,81,1.24 [0.88-1.76],0.2189875738373718
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,19531,385,1.23 [1.04-1.44],0.0147159466495536
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,18541,385,0.95 [0.77-1.18],0.6471819762687068
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,19021,397,0.88 [0.70-1.10],0.2589654187139488
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",18713,89,0.60 [0.34-1.08],0.0887382596814794
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,18875,251,0.97 [0.75-1.27],0.847226732666972
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,19625,76,0.83 [0.49-1.41],0.4855408882180289
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,19611,62,0.76 [0.41-1.41],0.3901885192047825
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,19597,48,0.83 [0.43-1.63],0.591123836438459
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,19589,40,1.43 [0.95-2.15],0.0877110042852584
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,19588,39,1.42 [0.93-2.16],0.1044033930961022
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,19196,50,1.46 [1.05-2.04],0.0247761462075464
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,19457,311,1.16 [0.95-1.41],0.1369189049017905
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,18229,73,0.87 [0.52-1.47],0.6076767088131869
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,18192,36,0.98 [0.50-1.91],0.945586280801042
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,18190,34,0.79 [0.35-1.78],0.5670750700298681
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",18307,151,0.96 [0.69-1.34],0.8093706553372242
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,18293,137,1.00 [0.71-1.41],0.9942761166732872
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,14695,2964,1.02 [0.94-1.11],0.5587450686740221
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,15931,1750,1.05 [0.95-1.16],0.3409361862443202
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,17961,911,0.95 [0.83-1.10],0.5189670259036879
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,14252,71,1.25 [0.85-1.82],0.2591192447140624
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,14506,325,1.11 [0.91-1.37],0.3035166975203015
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",19616,68,1.24 [0.84-1.84],0.2831740694918321
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,19618,59,1.30 [0.87-1.93],0.1956287944190496
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,15070,889,1.04 [0.90-1.19],0.5991693560253301
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",17092,889,1.02 [0.89-1.17],0.7869331123533196
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,14284,103,1.16 [0.82-1.64],0.4137763708766927
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",19070,99,1.16 [0.82-1.65],0.3988723251648933
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,14312,131,1.06 [0.75-1.50],0.7222599942594474
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,14223,42,0.87 [0.43-1.76],0.6955225960954097
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,14399,218,1.10 [0.86-1.41],0.4386444720847905
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",19741,106,0.80 [0.50-1.26],0.3288434509038076
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,14665,484,0.98 [0.81-1.18],0.8285653818481393
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,14426,245,1.08 [0.84-1.38],0.5584842687203078
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,15159,978,1.03 [0.91-1.17],0.6482005006167973
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),14202,21,0.93 [0.36-2.41],0.882335842483857
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),14220,39,1.04 [0.56-1.92],0.908300363233827
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,14203,22,1.32 [0.70-2.49],0.3859410930495885
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),14194,13,0.99 [0.33-2.98],0.984301104734798
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,14683,502,0.93 [0.77-1.12],0.4598128616425173
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,14621,440,0.92 [0.75-1.13],0.4346179209203659
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,16059,217,1.21 [0.97-1.51],0.0899179371318139
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,19605,35,0.91 [0.44-1.89],0.8009414552217018
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,19585,15,0.83 [0.25-2.77],0.7634286017815305
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,17382,38,0.67 [0.29-1.56],0.3531356241450067
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,17588,244,0.86 [0.64-1.16],0.3181770866864407
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,18038,694,0.87 [0.73-1.03],0.1085094623096082
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,17484,140,0.87 [0.59-1.28],0.4832398973579438
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,17421,77,0.65 [0.35-1.18],0.1567276810642549
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",17887,543,0.87 [0.71-1.05],0.1473324103534322
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,17387,43,0.88 [0.45-1.73],0.7092698004681379
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,17542,198,0.79 [0.56-1.11],0.175514953930757
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,17428,84,0.91 [0.58-1.45],0.6990121919305435
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,17397,53,1.10 [0.67-1.79],0.7056417652493513
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,17443,99,0.55 [0.31-0.96],0.0348202195422332
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,17384,40,1.06 [0.58-1.91],0.8598124206331891
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,17564,220,0.92 [0.69-1.23],0.5795858499333535
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,17250,200,0.96 [0.71-1.28],0.760765339862934
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,17103,53,0.94 [0.52-1.69],0.8247973486964775
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,17107,57,0.97 [0.56-1.68],0.9268247792959692
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,17101,51,0.94 [0.52-1.69],0.832267385260268
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",17101,51,1.41 [0.99-2.01],0.0573830637964685
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,17197,147,0.92 [0.64-1.32],0.6518490324258714
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],17189,139,0.93 [0.64-1.34],0.6838043918202268
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,17251,201,0.92 [0.68-1.25],0.6081869317771313
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,17093,43,0.77 [0.37-1.61],0.4860424881036748
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,17120,70,0.99 [0.60-1.63],0.977575647180349
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,17143,93,0.88 [0.55-1.40],0.5875028119311444
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,17087,37,0.66 [0.28-1.57],0.3500169426145445
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",17348,298,0.90 [0.69-1.16],0.4046845223457241
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,17176,126,0.90 [0.61-1.34],0.6015603357300447
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,17210,160,0.89 [0.62-1.27],0.5168781060191294
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,19014,86,1.15 [0.78-1.69],0.4842185460081573
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,19172,244,0.97 [0.74-1.26],0.806625902890293
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,18975,47,0.83 [0.42-1.63],0.5874511652339098
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,18973,45,0.58 [0.26-1.30],0.1891036633810071
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,19005,77,0.81 [0.48-1.38],0.4454534749074611
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,15261,1915,1.01 [0.92-1.12],0.7794210862218012
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,17117,1048,1.01 [0.89-1.15],0.8933394891715813
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,17644,208,1.02 [0.77-1.35],0.8812595105861161
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,17506,70,1.16 [0.76-1.78],0.4854638905093429
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Acute renal failure,17700,49,1.16 [0.70-1.93],0.5654454430000764
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,17698,47,1.22 [0.75-1.98],0.4320219986574124
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,17713,62,0.72 [0.38-1.36],0.3106070480992315
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Urolithiasis,19432,298,1.00 [0.80-1.26],0.9782162704366104
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,19437,55,1.06 [0.63-1.78],0.8197788351570295
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,19346,212,1.03 [0.79-1.34],0.8354745748773915
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,19247,113,0.84 [0.55-1.29],0.4260937101476094
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,18044,688,0.97 [0.83-1.14],0.6945841866358211
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Cystitis,17401,45,0.82 [0.41-1.64],0.5792938074262663
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,17417,61,1.09 [0.68-1.75],0.7291148427416634
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,17667,311,0.87 [0.68-1.12],0.2906312615594072
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Urethral stricture,17470,114,1.13 [0.81-1.57],0.4707375141883025
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,17665,309,0.93 [0.73-1.19],0.5717779617192392
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,16531,462,0.88 [0.71-1.09],0.2411902293480275
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),16158,89,1.04 [0.70-1.57],0.8332945078880897
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Hydrocele,16156,87,1.11 [0.75-1.64],0.5938538347939375
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",16201,132,1.18 [0.88-1.58],0.2779818959459118
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,16201,132,1.13 [0.83-1.55],0.4349588261721999
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,16240,171,1.13 [0.86-1.48],0.3713314911760669
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",19437,61,1.00 [0.60-1.68],0.9906629676534584
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Falls/tendency to fall,18106,460,0.98 [0.81-1.18],0.8039600733006578
